MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability

    S. Couth, E. Poliakoff, J. Vega, C. Jay, S. Harper, R. Almutiry, T.F. Cootes, A.M. Ramsay, S.A. Kotz (Manchester, United Kingdom)

    Objective: The objectives of this study were twofold. First, to determine the feasibility of monitoring changes in how people with Parkinson's feel, think, and behave…
  • 2016 International Congress

    The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease

    D. Kuebler, H. Schroll, R. Eva, A. Diepold, C. Meyer, A. Kuhn (Berlin, Germany)

    Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…
  • 2016 International Congress

    Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA

    M.M.C.M. Brito, R.S.J. Silva, V. Tumas, I.F. Mata, C.Z. Zabetian (Ribeirão Preto, Brazil)

    Objective: Analysing the relationship between the polymorphisms of ApoE gene and cognitive performance of patients with Parkinson's disease. Background: Cognitive impairment is a common clinical…
  • 2016 International Congress

    Illusional perception in Parkinson’s disease

    C. Ding, C. Palmer, J. Hohwy, G. Youssef, B. Paton, N. Tsuchiya, J. Stout, D. Thyagarajan (Clayton, Australia)

    Objective: To investigate (a) whether a susceptibility to illusional perceptions is intrinsic to Parkinson's disease even before the onset of hallucinations or cognitive impairment and…
  • 2016 International Congress

    Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

    E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

    Objective: To ascertain the prevalence of problematic technology use (Technology-related ICDs, Tech-ICDs) in patients with PD. Background: ICDs are a known complication of PD drugs…
  • 2016 International Congress

    Factors related to psychotic symptoms in patients with Parkinson’s disease

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: The aim of this study was to compare clinical characteristics in Parkinson's disease (PD) with psychosis (PDP) versus PD without psychosis (PDnP) and evaluate…
  • 2016 International Congress

    Choreoathetosis associated with cervical dystonia as clinical presentation of thyrotoxicosis: A rare condition

    S.C.B. Casagrande, S.M.C.d.A. e Silva (São Paulo, Brazil)

    Objective: To describe the first report of Cervical Dystonia and Choreoatetosis associated in the same patient with hyperthyroidism (thyrotoxicosis). Background: Thyroid Disease is related with…
  • 2016 International Congress

    iPad-based preassessment questionnaires are feasible in a Parkinson’s service

    B. Mohamed, E.L. Lane, E.C. Thomas, M. Landwehr, C.W. Ngu, J. Butler, K. Williams, M. Wardle (Cardiff, United Kingdom)

    Objective: To determine the feasibility of using a iPad-based preassessment app in a Parkinson's service. Background: Parkinson's patients have a core motor disorder, a host…
  • 2016 International Congress

    Pantotenate kinase associated neurodegeneration (PKAN): Proposal for a clinical rating scale

    A. Darling, C. Garrido, S. Aguilera, M. Tomas-Vila, I. Gaston, M. Madruga, L. González-Gutiérrez, J. Ramos-Lizana, M. Pujol, K. Tustin, J.P. Lin, L. Martorell, C. Tello, V. Lupo, C. Espinos, L. Stefanis, L. Sanz, F. Gutiérrez, P.J. Garcia, L. Vela, T. Temudo, R. Pons, M.J. Martí, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: To design and validate a quantitative method for the assessment of PKAN patients. Background: Despite advances in the research of novel therapies for PKAN,…
  • 2016 International Congress

    Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)

    J.A. Simons, S. von Clarmann, T. Warnecke (Lübeck, Germany)

    Objective: A new FEES protocol specified for dysphagia diagnosis among Parkinson's disease (PD) patients was recently developed in a prior two-phased study¹, which is now…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley